Latest stories on ZYME
Zymeworks Inc. (ZYME) Discusses Portfolio Strategy, Roche Partnership and Pipeline Updates - Slideshow
Seeking Alpha56 · neutralproduct/pr
ZYME Maintained by Truist Securities -- Price Target Raised to $35
GuruFocus63 · neutralanalyst
Zymeworks Inc. (ZYME) Discusses Portfolio Strategy, Roche Partnership and Pipeline Updates Transcript
Seeking Alpha58 · neutralproduct/pr
Truist raises Zymeworks stock price target on pipeline progress
Investing.com Analyst Ratings64 · neutralanalyst
Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
StockTitan53 · neutralgeneral
Zymeworks stock price target reaffirmed at $32 by Citizens
Investing.com Analyst Ratings56 · neutralanalyst
Zymeworks presents new clinical data from Phase 1 study of ZW191
The Fly61 · neutralproduct/pr
Zymeworks presents new clinical data on Phase 1 study of ZW191
The Fly58 · neutralproduct/pr
Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer
Seeking Alpha64 · neutralproduct/pr
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
StockTitan64 · neutralproduct/pr
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
Business Insider64 · neutralproduct/pr
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
GlobeNewswire64 · neutralproduct/pr
Jefferies raises Zymeworks stock price target on Roche deal
Investing.com Analyst Ratings64 · neutralanalyst
Zymeworks price target raised to $52 from $50 at Jefferies
The Fly63 · neutralanalyst
Why is Zymeworks stock surging today?
Investing.com Markets64 · neutralgeneral
Zymeworks stock surges on $813M Roche licensing deal
Investing.com Markets78 · bullishproduct/pr
Zymeworks, Roche Enter Collaboration to Develop Experimental Lung Cancer Drug
MarketWatch64 · neutralproduct/pr
Zymeworks Inc. (ZYME) files 8-K
SEC 8-K50 · neutralgeneral
Zymeworks signs collaboration and license agreement with Roche for ZW209
The Fly64 · neutralproduct/pr
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
Business Insider74 · bullishproduct/pr
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
GlobeNewswire53 · neutralgeneral
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
Business Insider53 · neutralgeneral
Zymeworks Sets Q3 2026 Results Date and Ramps Up Investor Conference Presence
TipRanks52 · neutralgeneral
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
GlobeNewswire52 · neutralgeneral